logo
Select company
Select metric
$ -7.31MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
27
Sector
65
Industry
59
History
95
$ 0.89Close
$ 0.74 - $ 1.31 52-Week Range
Ticker Information

Ticker

CTSO

Company Name

CYTOSORBENTS CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

CYTOSORBENTS CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CTSO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.7M$ -9.01M$ -7.31M
3/31/2025$ 1.71M$ -15.53M$ -13.83M
12/31/2024$ 1.74M$ -21.01M$ -19.27M
9/30/2024$ 2.11M$ -18.66M$ -16.55M
6/30/2024$ 2.15M$ -26.07M$ -23.93M
3/31/2024$ 2.16M$ -28.25M$ -26.1M
12/31/2023$ 2.03M$ -29.16M$ -27.14M
9/30/2023$ 1.51M$ -24.48M$ -22.97M
6/30/2023$ 1.33M$ -27.57M$ -26.24M
3/31/2023$ 1.16M$ -32.33M$ -31.16M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CYTOSORBENTS CORP's latest trailing twelve months (TTM) EBITDA stands at $ -10.39M.
  • Over the past 5 years, CYTOSORBENTS CORP's average EBITDA has been $ -21.4M.
  • The median EBITDA for CYTOSORBENTS CORP during this period was $ -23.45M
  • CYTOSORBENTS CORP reached its highest EBITDA over the past 5 years at $ -7.1M.
  • The lowest EBITDA recorded by CYTOSORBENTS CORP in the same timeframe $ -40.72M

CYTOSORBENTS CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SRTS : SENSUS HEALTHCARE INC $ 47KMDAI : SPECTRAL AI INC $ -13.22MECOR : ELECTROCORE INC $ -12.11MMYO : MYOMO INC $ -7.41MAPYX : APYX MEDICAL CORP $ -10.51MICCC : IMMUCELL CORP $ 4.47MMGX : METAGENOMI INC $ -79.73MSSKN : STRATA SKIN SCIENCES INC $ -4.44MELUT : ELUTIA INC $ -14.01MFORA : FORIAN INC $ -231.53K

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CYTOSORBENTS CORP is calculated as follows: EBIT [ $ -11.05M ] + DepAmor [ $ 662.41K ]
(=) EBITDA [ $ -10.39M ]

CTSO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -40.72M

Minimum

Sep 30, 2022

$ -7.1M

Maximum

Dec 31, 2020

$ -21.4M

Average

$ -23.45M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M